The clinical significance of isocitrate dehydrogenase 2 in esophageal squamous cell carcinoma

Isocitrate dehydrogenase 2 (IDH2) is the rate-limiting enzyme in the tricarboxylic acid (TCA) cycle in cellular metabolism. Growing evidence indicates that IDH2 plays a crucial role in the development of cancer. We aimed to investigate the expression level of IDH2 and its prognostic value in esophag...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Chen, Xuan, Xu, Wenzhe, Wang, Cong, Liu, Fang, Guan, Shanghui, Sun, Yi, Wang, Xintong, An, Dianzheng, Wen, Zhihua, Chen, Pengxiang, Cheng, Yufeng
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5385653/
https://ncbi.nlm.nih.gov/pubmed/28401022
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars